Greenstone Biosciences
PrivateLast Round
Grant
May 15, 2024
Total Funding Raised
$27.26M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Greenstone Biosciences is a biotechnology company that operates a drug discovery platform integrating artificial intelligence, machine learning, and human-induced pluripotent stem cell (hiPSC) technology to accelerate the development of effective therapies.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Greenstone Biosciences Comparables
Compare Greenstone Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vivodyne | 88% | |
| VALID Therapeutics | 85% | |
| Quris AI | 84% | |
Greenstone Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 15, 2024 | ||||
| Grant | Apr 29, 2024 | ||||
| Grant | Sep 5, 2023 | ||||
| Grant | Dec 7, 2022 | ||||
| Grant | Oct 4, 2022 | ||||
Seed | May 4, 2022 |
Greenstone Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| A&E Investments | Seed |
| Walden Catalyst | Seed |
| California Institute for Regenerative Medicine | Grant |
| Mayfield Fund | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
Monthly visitors grew 228% MoM, reaching 28.6K.
Greenstone Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Greenstone Biosciences's valuation, stock price, and market status.